Key result
Statins may decrease AF incidence and recurrence after cardioversion and ablation by modulating inflammation.
Why the study?
Atrial fibrillation prevalence and associated morbidity are rising, prompting interest in whether statins can prevent incident AF or reduce recurrence after cardioversion and catheter ablation.
Do statins prevent the incidence or recurrence of atrial fibrillation in general and specific populations?
Do statins prevent the incidence or recurrence of atrial fibrillation in general and specific populations?
This review summarizes current knowledge on the potential role of statins in the primary and secondary prevention of atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for statins in AF prevention; prospective RCTs needed before clinical adoption.
Atrial fibrillation is the most common arrhythmia in adults and its prevalence is growing rapidly. It has been shown that AF is associated with increased risk of heart failure, ischemic and hemorrhagic stroke, and mortality. Hence, there is growing interest among researchers in seeking preventive and therapeutic interventions regarding AF. In recent decades, it has been suggested that statins may decrease the incidence of AF and may also decrease its recurrence after cardioversion and catheter ablation. These effects are thought to be mediated by different mechanisms such as modulating inflammation, altering the properties of transmembrane ion channels, interfering with activation of matrix metalloproteinases, and acting on endothelial function. In this article, we review and update current knowledge about the role of statins in primary and secondary prevention of AF in general and specific populations. A fibrilação auricular (FA) é a arritmia mais comum em adultos e a sua prevalência está a crescer rapidamente. Foi demonstrado que a FA está associada a um risco acrescido de insuficiência cardíaca, acidente vascular cerebral isquémico e hemorrágico e mortalidade. Assim, há um interesse crescente entre os investigadores na procura de intervenções preventivas e terapêuticas em relação à FA. Nas últimas décadas, tem sido sugerido que as estatinas podem diminuir a incidência de FA e também diminuir a sua recorrência após a cardioversão e ablação do cateter. Pensa-se que estes efeitos são mediados por diferentes mecanismos, tais como a modulação da inflamação, a alteração das propriedades dos canais de iões transmembrana, a interferência com a ativação das metaloproteinases matriciais e a atuação sobre a função endotelial. Neste artigo, revemos e atualizamos os conhecimentos atuais sobre o papel das estatinas na prevenção primária e secundária da FA em populações gerais e específicas.
No takes yet. Share an insight, caveat, or question.
Oraii et al. (2021) conducted a review in Atrial fibrillation. Statins was evaluated. Statins may decrease the incidence of atrial fibrillation and its recurrence after cardioversion and catheter ablation through mechanisms like modulating inflammation and endothelial function.
Synapse has enriched 10 related papers. Consider them for comparative context: